INTRODUCTION 7
Nearly two-thirds of Alström syndrome patients present with dilated cardiomyopathy and 145 congestive heart failure contributes to a significant portion of the reported mortality (19) . The 146 earliest manifestation of cardiomyopathy in zebrafish is cardiac edema, which results from failed 147 contractility, loss of vascular integrity or ventricular malformations and can develop by 48 hpf 148 (20) . Compared to 2.5% of wild type control animals generated from sibling clutch-mates, 18% 149 of alms1 -/embryos exhibited cardiac edema at 48 hpf (Fig 2A-B) . Although this reflected a 6-150 fold increase in edema (p<0.0001; Observed vs Expected), the majority of alms1 -/embryos 151 appeared largely normal (Fig 2A-B) . To examine the possibility of a progressive cardiac 152 phenotype, we also examined the morphology of age-matched adult hearts in alms1 -/animals.
153
We observed smaller hearts in the adult alms1 -/fish when compared with wildtype controls (Fig   154   2C '). Closer examination revealed a loss of ventricular wall integrity in the alms1 -/fish ( Fig 2C" ).
155
These findings are consistent with cardiomyopathy in Alström, including the reported variability 156 in phenotypic presentation in patients (19) . 8 shown). Together with the histological findings, these data implicate Alms1 in maintenance of 171 retinal sensory epithelia and visual function.
172
Nearly half of Alström patients have reported renal failure accompanied by a broad range of 173 defects including calculi, interstitial fibrosis, and glomerulosclerosis (4). We examined gross 174 kidney morphology in H&E-stained sections of kidneys from alms1 +/+ adults, and observed well-175 formed tubule structure of varying intensities, indicating distal (lighter stain, yellow arrow) and 176 proximal (darker stain, red arrow) tubules ( Fig 2F) . The alms1 -/kidney sections contained 177 apparent interstitial degradation and distal and proximal tubules were dilated compared to 178 control animals ( Fig 2F, colored arrows) . These observations are consistent with degradation of 179 the tubules and interstitial space and with previously reported phenotypes in Alms1 -/mice (18). Having confirmed the presence of previously reported prominent multi-organ features in the 183 alms1 -/zebrafish (4,18,19) , we explored the possibility of metabolic defects. Alström patients 184 exhibit high rates of early onset obesity coupled with hyperinsulinemia and progression to frank 185 T2DM, often as early as the second decade of life (4). To examine the possibility of increased 186 weight gain, we subjected adult wild type or mutant fish clutch-mates to an 8-week dietary 187 regimen consisting of either regular pellet diet (control diet) or a ten-fold increased weight of 188 pellet diet supplemented with five-fold weight of egg yolk powder (high fat diet) (22, 23) . alms1 +/+ 189 fish did not gain significant weight on the control diet, but the high fat diet produced an increase 190 of 1.9-fold over the starting weight at 8 weeks in these animals (p=0.033; Two-Way ANOVA; Fig   191   3A -B). By comparison, the alms1 -/fish gained weight under all dietary conditions. Control diet in 192 alms1 -/fish resulted in a 1.6-fold increase over starting weight and the high fat diet produced a 193 3.2-fold increase in weight over the 8-week time period. Notably, significant weight gain was 9 not observe quantifiable differences in food intake at larval stages, as such we propose that the 196 obesity phenotype is unrelated to central regulation of satiety or hunger ( Fig S1B) .
197
The truncal obesity typically observed in Alström patients is often accompanied by hepatic 198 steatosis, a common hepatic manifestation of metabolic syndrome. Fatty liver has been reported 199 in a substantial proportion of patients as well as mouse Alström models (4, 18) . To determine if 200 mutant zebrafish exhibit abnormal accumulation of hepatic lipids, we stained wholemount 6 dpf 201 larvae with Oil Red O and examined neutral lipid content in the liver ( Fig 3C) . Only 18% of 202 alms1 +/+ embryos exhibited observable and dense Oil Red O staining in their livers, while 82% 203 of alms1 -/embryos exhibited excess fat deposition (p<0.0001; Observed vs Expected; Fig 3C) .
204
By adult stages this was accompanied by hypertrophy of hepatopancreata of alms1 -/fish, 205 demonstrated by increased cell density when compared to age-and section-matched wild type 206 animals ( Fig 3D) .
207
Excessive weight gain and hepatic steatosis are indicative of metabolic dysfunction and 208 could suggest insulin resistance and impaired glucose disposal. To evaluate glucose uptake in 209 alms1 mutant fish, we exposed 6 dpf larvae to 2-(N-(7-Nitrobenz-2oxa-1,3-diazol-4-yl)Amino)-2-
210
Deoxyglucose (2-NBDG), a fluorescently labeled glucose analog, and quantified fluorescence 211 intensity in larval kidneys after 4 hours (24). alms1 +/+ animals exhibited a dose-dependent 212 increase in fluorescence upon exposure to increasing concentrations, reaching a 9.75-fold ± 213 3.53 increase over baseline with 1000 μM 2-NBDG (p=0.0003; Two-Way ANOVA; Fig 3E) . 
229
which is a reduction from the 31.9 ± 1.0 β-cells per fish in controls (p<0.0001; Student's t-test;
230 Fig 4B) . Given the reduced β-cell mass in alms1 -/animals at all stages, we hypothesized an 231 inability to appropriately sense and regulate systemic glucose in alms1 -/animals. Proper 232 sensing of high glucose conditions results in expansion of β-cell mass (25). We evaluated this 233 response using alms1 +/progeny treated with either glucose-free standard embryo media or 234 media supplemented with high glucose (40 mM) from 24-120 hpf. Larvae were fixed and 1 1 exogenous cues. To better understand how loss of alms1 may impact β-cell function, we 246 generated single-cell homogenates from 5 dpf larvae of either wildtype Tg(insa:mCherry) or 247 Tg(insa:mCherry);alms1 -/and isolated the mCherry+ cells via FACS sorting ( Fig 5A) (26). Using
248
RNA from the isolated cells, we carried out whole transcriptome analysis via 27) .
249
Using a cut-off for differentially expressed genes of a fold change of greater than 1 or less than -250 1, we identified a total of 3,880 up-regulated genes and 5,531 down-regulated genes in the 251 alms1 -/β-cells compared to β-cells isolated from wild type larvae ( Fig 5B) . We first confirmed 252 the β-cell-enriched nature of these cells by confirming elevation of islet and β-cell markers,
253
relative to markers of other cell types ( Fig 5C) . We then carried out pathway analysis of 254 significantly changed genes and found that the down-regulated genes in mutant β-cells strongly 255 supported a generalized decrease in cellular activities, protein and RNA processing, consistent 256 with the significant apoptosis that we previously reported ( Fig S2) (15). Over-represented terms 257 in the set of upregulated genes were in large part related to cellular transport and secretion (37 258 of 74 categories) and cell membrane ion transport ( Fig S3A) . These findings support a role for 259 alms1 in regulation of secretion and membrane depolarization in β-cells. We also identified a 260 group of significantly abundant pathways in the up-regulated genes with known pancreatic 261 functions ( Fig S3B) . These genes can be clustered into those implicated in monogenic diabetes, 262 nutrient transport (mainly metal ion and amino acids carriers), insulin secretion (including 263 calcium and potassium channels), and generalized pancreatic secretion ( Fig 5C) . The
264
intersections of these pancreas-related pathways contain a subset of six genes, including 265 slc2a2/glut2, found in 3 pathways, and insulin, found in 2 pathways (red numbers, Fig 5C) .
267
Depletion of Alms1 in cultured β-cells impairs glucose challenge response 1 2 be linked to dysregulated insulin secretion in the absence of Alms1. Thus, we evaluated the 271 mechanism by which ALMS1 impacts insulin secretion using a simplified cultured mouse β-cell 272 model, MIN6.
273
Alms1 knockdown was accomplished via transient siRNA transfection (si-Alms1) with an 274 average of 0.38 ± 0.04 Alms1 expression compared to control levels (p<0.0001; Student's t-test;
275 Fig S1C) . We next examined the genes implicated by RNA-Seq in cultured β-cells. When 276 exposed to 16.7 mM glucose, physiological high glucose conditions, control cultured β-cells 277 showed an increase in adenylyl cyclase 5 (Adcy5) and calcium/calmodulin-dependent protein 278 kinase 2b (Camk2b), both known to transmit signals downstream of glucose transport in murine 279 β-cells, along with moderate changes to Pklr, which initiates intracellular glucose processing 280 and alters cellular metabolism, and Slc2a2, the main murine glucose transporter ( Fig 5E) (28).
281
Of note, the si-Alms1 β-cells exhibited a dampened Adcy5 response and higher levels of 282 Camk2b gene expression profiles (p= 0.002; Two-Way ANOVA) irrespective of glucose levels 283 ( Fig 5E) . This appeared to be accompanied by a failure to alter Pklr and Slc2a2 expression in 284 response to glucose ( Fig 5E) . In fact, Pklr appeared to mimic high glucose control conditions 285 even in si-Alms1 β-cells cultured in low glucose conditions ( Fig 5E) , suggesting an inability to 286 properly sense glucose and regulate gene expression.
287
These gene expression data led us to hypothesize that the si-Alms1 β-cells would potentially 288 exhibit inappropriate insulin secretion in response to high glucose. The secreted insulin upon 289 stimulation with physiological high glucose in si-Alms1 β-cells was evaluated using high-
290
sensitivity ELISA based quantification. The control β-cells required 10 minutes to begin 291 secreting insulin in response to high glucose, and reached 2.2-fold the unstimulated insulin 292 levels by 30 minutes (Fig 5F) . The si-Alms1 β-cells showed 1.6-fold higher levels of secreted 293 insulin than control β-cells without glucose stimulation ( Fig 5F) . After 30 minutes of high 1 3
Two-Way ANOVA; Fig 5F) . These data suggest a modest hypersecretory basal state in 331 appropriate β-cell glucose sensing. We used a simplified β-cell culture system to examine these 332 aspects individually. Knockdown of Alms1 resulted in excess secreted insulin without glucose 333 stimulation, but failure to respond to high glucose stimulation at the level of either insulin 334 secretion or altered gene expression ( Fig 5) . Epistatic analysis of the glucose-sensing and 335 insulin response pathways in Alms1 knockdown or knockout β-cells will be important to identify 336 the exact genetic pathway defects in those cells and could be confirmed in the alms1 -/animals.
337
The molecular mechanism by which Alms1 impacts secretion is unknown, and such studies For histological analyses, adult fish-approximately six months in age-were sacrificed in 370 0.05% tricaine (3-amino benzoic acid ethyl ester) until unresponsive (Sigma). The tail segment 371 behind the anal fin was removed using a razor blade and samples were fixed for 24 hrs in 372 Dietrich's solution (30% ethanol, 10% formalin, 2% glacial acetic acid) then decalcified in 0.5 M 373 ethylenediaminetetraacetic acid for 7 days. Samples were processed for cryo-sectioning using 374 serial sucrose gradient before being embedded in optimal cutting temperature (OCT) compound 375 (Tissue-Tek). Samples were sectioned into 10 µM thick transverse sections and mounted.
376
Hemotoxylin (Thermo Scientific) and Eosin Y (95%, Sigma) staining was performed to evaluate 377 overall tissue morphology. Aldehyde fuchsin staining (18) 
448
Glucose stimulation of cultured β-cells was performed on cells plated at equal densities, as 449 determined by hemocytometer counts, using 2.5 mM and 16.7 mM glucose as baseline and 450 high glucose concentrations, respectively. Insulin was assessed in media collected at the neurod1  irs2b  isl1  irs2a  pdx1  irs4a  irs1  pax6a  insb  pax6b  ins  pax4  pbx1a  spp1  pbx1b  alx4b  rankl  opg  balp  kdrl  myh6  kdr  myl7  clmc2  mitfa  tyr  mitfb  lgr5 
